Brief: Emergent BioSolutions Announces Sale Of Baltimore-Camden Manufacturing Site To Bora Pharmaceuticals
20/06/2024 12:46
June 20 (Reuters) - Emergent BioSolutions:
* EMERGENT BIOSOLUTIONS ANNOUNCES SALE OF BALTIMORE-CAMDEN
MANUFACTURING SITE TO BORA PHARMACEUTICALS FOR $30 MILLION
* EMERGENT BIOSOLUTIONS: ALONGSIDE FACILITY, ABOUT 350
CURRENT
EMERGENT EMPLOYEES ARE EXPECTED TO JOIN BORA AS PART OF DEAL
Source text for Eikon: ID:nGNX4NnCsT
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BORA PHARMACEUTICALS
See all newsAI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln